Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models

相似書籍

• Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model
  由: ABBA, MARTÍN C., et al.
  出版: (2009)
• The Combination of Tamoxifen and the Rexinoid LG100268 Prevents ER-Positive and ER-Negative Mammary Tumors in P53-Null Mammary Gland Mice
  由: Mazumdar, Abhijit, et al.
  出版: (2012)
• The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor
  由: Li, Yuxin, et al.
  出版: (2010)
• Prevention of tumorigenesis in p53 null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib and celecoxib
  由: Medina, D., et al.
  出版: (2009)
• A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours
  由: Yen, W-C, et al.
  出版: (2006)